Do Probiotics Affect Vaginal Odor?

Quick answer

Yes, certain probiotic strains, particularly specific Lactobacillus strains, have evidence supporting their potential to improve vaginal odor associated with bacterial vaginosis by restoring normal vaginal flora and reducing odor-related symptoms.

🔬 What the research shows

Multiple high-quality randomized controlled trials and systematic reviews indicate that probiotics, especially Lactobacillus strains such as Lactobacillus acidophilus, Lactobacillus rhamnosus (including GR-1), Lactobacillus reuteri (including RC-14), Lactobacillus crispatus, Lactiplantibacillus plantarum, and Lactobacillus fermentum, can help restore normal vaginal microbiota in women with bacterial vaginosis (BV). This restoration is associated with improvements in clinical symptoms including vaginal odor, discharge, and Nugent scores. Vaginal administration of probiotics often shows more direct effects, but oral administration also demonstrates benefits. Some studies also show that probiotics reduce recurrence rates of BV. Safety profiles are generally favorable with mild and self-limiting side effects reported. However, evidence is heterogeneous with some studies showing no significant benefit, and strain-specific effects are important. More large-scale, well-designed trials are needed to confirm optimal strains, doses, and administration routes. Probiotics have not been shown to directly treat vaginal odor unrelated to BV or other conditions.

Best studied probiotic strains

Lactobacillus acidophilus

Moderate evidence from a clinical trial (PMID 17532736) showed that vaginal douche containing L. acidophilus significantly reduced vaginal pH and odor in women with bacterial vaginosis, improving Nugent scores and whiff test results.

Effective in vaginal douche form; evidence moderate and from a pilot study.

Lacticaseibacillus rhamnosus (including GR-1)

High-quality RCTs and systematic reviews (PMIDs 17045832, 16697231, 24283058, 18854803, 18843900) demonstrate that L. rhamnosus strains improve BV cure rates, reduce recurrence, restore vaginal flora, and reduce symptoms including odor. Oral and vaginal administration both effective.

Strain-specific effects important; often combined with L. reuteri RC-14.

Lactobacillus reuteri (including RC-14)

RCTs (PMIDs 17045832, 16697231, 18854803) show that L. reuteri RC-14 combined with L. rhamnosus GR-1 improves BV treatment outcomes and reduces odor and discharge symptoms.

Usually studied in combination with L. rhamnosus GR-1.

Lactobacillus crispatus (including CTV-05)

High-quality RCTs (PMIDs 19543144, 20644497) show that vaginal administration of L. crispatus CTV-05 is safe, colonizes the vagina, and may help prevent BV recurrence and improve vaginal health.

Colonization after vaginal administration demonstrated; safety profile good.

Lactiplantibacillus plantarum

Low to moderate evidence (PMID 25291116, 35633296) supports vaginal administration of L. plantarum strains reducing Nugent scores and inhibiting Gardnerella vaginalis growth, potentially improving BV symptoms including odor.

Evidence from pilot studies; promising candidate for vaginal probiotics.

Limosilactobacillus fermentum

Low to moderate evidence (PMIDs 25291116, 20472091, 24641524) indicates L. fermentum strains can inhibit G. vaginalis and improve BV symptoms including malodor when administered vaginally.

Often studied in combination with other lactobacilli.

Bifidobacterium longum BB536

High evidence (PMID 42046285) shows BB536 improves odor-related metabolites in gut microbiota subgroups but study focused on gastrointestinal symptoms in male athletes, not vaginal odor.

No direct evidence for vaginal odor; included for completeness.

View products containing microorganisms linked to this analysis

👥 Who may benefit

Women diagnosed with bacterial vaginosis experiencing vaginal odor Women seeking adjunctive therapy to antibiotics for bacterial vaginosis Women with recurrent bacterial vaginosis aiming to reduce recurrence Women preferring probiotic approaches for vaginal health maintenance

✅ Safety

Probiotics studied for vaginal health are generally safe and well tolerated. Mild, self-limiting adverse events such as vaginal discharge, abdominal discomfort, or irritation have been reported. No serious adverse events or safety concerns were noted in high-quality trials. Vaginal and oral probiotic administration routes are both considered safe.

⚠️ Limitations

Evidence is heterogeneous with variability in probiotic strains, doses, administration routes, and study designs. Some studies have small sample sizes or are pilot trials. Strain-specific effects are critical; not all probiotics are equally effective. Most evidence pertains to bacterial vaginosis-related odor, not other causes of vaginal odor. Long-term efficacy and optimal treatment regimens require further research. Some studies report no significant benefit over placebo or standard treatment.